Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Gene expression profile guiding personalized SMAC mimetic therapy in pediatric precursor B-cell ALL

May 20, 2020

New JAK1 inhibitors presented by Lynk Pharmaceuticals

May 20, 2020

Jiangsu Simcere Pharmaceutical synthesizes EGFR mutant inhibitors

May 20, 2020

Subdividing and conquering PDAC

May 20, 2020

Phase IIb study of Liproca Depot in prostate cancer meets endpoints

May 19, 2020

New ATR kinase inhibitors identified by Repare Therapeutics

May 19, 2020

Arrien Pharmaceuticals synthesizes MELK and/or FLT3 inhibitors

May 19, 2020

Incyte presents novel PI3K-gamma inhibitors

May 19, 2020

FDA approves Qinlock for fourth-line treatment of advanced GIST

May 18, 2020

FDA grants accelerated approval to Rubraca for BRCA-mutated metastatic CRPC

May 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...